The Journal of Urology

The Journal of Urology The official journal of the AUA, The Journal of Urology® is the most widely read and highly cited p

In this editorial by Temitope Rude, the author highlights findings from Shenhar et al.'s study showing sacral neuromodul...
11/07/2025

In this editorial by Temitope Rude, the author highlights findings from Shenhar et al.'s study showing sacral neuromodulation is effective in older adults with mild to moderate cognitive impairment, challenging past concerns and offering guidance for safer, more inclusive care.

🔗 Click to read more: https://bit.ly/48JYYlN

This study found that cognitive impairment in older adults did not affect short-term success or outcomes of sacral neuro...
11/06/2025

This study found that cognitive impairment in older adults did not affect short-term success or outcomes of sacral neuromodulation for overactive bladder, though it was linked to lower comfort and confidence with device use.

🔗 Click the link to read more: https://bit.ly/4o4gvKp

11/05/2025

ARTICLE INSIGHTS! Thank you Dr. Jamin Brahmbhatt for your insights into "Ureteroscopy vs Shock Wave Lithotripsy for Lower Pole Renal Stones: Treatment Variation and Outcomes in a Surgical Collaborative." Click the link below to read the full article!

🔗 https://bit.ly/4nAVd6m

11/04/2025

ARTICLE INSIGHTS! Thank you Dr. Phil Pierorazio for your insights into, "Risk Factors for First-Year Recurrence in Patients With Synchronous Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy and Complete Metastasectomy." Click the link below to read the full article!

🔗 https://bit.ly/3WlGrF1

In this editorial by Drs. Sesilia Kammo and Kristen R. Scarpato, the authors review the PRIME trial, noting metformin di...
11/04/2025

In this editorial by Drs. Sesilia Kammo and Kristen R. Scarpato, the authors review the PRIME trial, noting metformin did not reduce metabolic syndrome risk in prostate cancer patients on ADT, but showed modest metabolic benefits—highlighting the need for further research.

🔗 Click to read more: https://bit.ly/43rJC1F

This study found that while metformin did not significantly reduce the risk of metabolic syndrome in prostate cancer pat...
11/03/2025

This study found that while metformin did not significantly reduce the risk of metabolic syndrome in prostate cancer patients undergoing androgen deprivation therapy, it did lead to meaningful improvements in body weight, waist circumference, and hemoglobin A1c—suggesting a potential role in mitigating ADT-related metabolic complications.

🔗 Click to read more: https://bit.ly/4qor0cM

10/31/2025

EDITOR'S CHOICE! Thank you Dr. Robert Siemens for highlighting the article "A Randomized Phase 3 Trial of Metformin in Patients Initiating Androgen Deprivation Therapy as Prevention and Intervention of Metabolic Syndrome: The PRIME Study" from this month's issue.

🔗 Click to read more: https://bit.ly/4qor0cM

This study found that a predictive model using residual mass size and tumor pathology improves decision-making for postc...
10/30/2025

This study found that a predictive model using residual mass size and tumor pathology improves decision-making for postchemotherapy surgery in nonseminomatous germ cell tumors, outperforming standard size-based strategies when the risk of adverse pathology is ≥ 20%.

🔗 Click to read more: https://bit.ly/46Rcra6

10/29/2025

🗣️ HEAR FROM THE AUTHOR! Thank you Dr. John DiBianco from the University of Florida for talking about your article "Ureteroscopy vs Shock Wave Lithotripsy for Lower Pole Renal Stones: Treatment Variation and Outcomes in a Surgical Collaborative."

🔗 Click to read the full article: https://bit.ly/4nAVd6m

In this editorial by Dr. Debasish Sundi, he highlights findings from Donahue et al.'s trial showing no benefit of prophy...
10/28/2025

In this editorial by Dr. Debasish Sundi, he highlights findings from Donahue et al.'s trial showing no benefit of prophylactic mesh in preventing parastomal hernias after radical cystectomy, emphasizing the need for alternative surgical innovations.

🔗 Click to read more: https://bit.ly/3WldM2Vff

In this article, a randomized trial finds that prophylactic mesh placement during ileal conduit formation does not reduc...
10/27/2025

In this article, a randomized trial finds that prophylactic mesh placement during ileal conduit formation does not reduce parastomal hernia rates, suggesting mesh should not be routinely used for prevention despite its safety profile.

🔗 Click the link to read more: https://bit.ly/4qmxYPB

In this article, researchers identify key risk factors—liver metastases, tumor size, and elevated C-reactive protein—for...
10/24/2025

In this article, researchers identify key risk factors—liver metastases, tumor size, and elevated C-reactive protein—for early recurrence in metastatic renal cell carcinoma patients rendered disease-free after surgery, supporting risk-based decisions for postoperative systemic therapy.

🔗 Click to read more: https://bit.ly/3WlGrF1

Address

1000 Corporate Boulevard
Linthicum, MD

Website

Alerts

Be the first to know and let us send you an email when The Journal of Urology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to The Journal of Urology:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category